Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Multimodal MRI biomarkers for optimizing deep brain stimulation therapy in Parkinson's disease.
EF 2021-22
Résumé
Deep brain stimulation (DBS) is a neurosurgical technique wherein implantable electrodes are placed in key brain structures to provide electrical stimulation and modulate pathological brain activity. It has become an effective and well-established therapy for Parkinsons disease (PD) and has shown benefit for an expanding number of motor, psychiatric, and cognitive disorders. Despite its recognized efficacy in PD, there is substantial variability in clinical response and there remains uncertainty as to which neuroanatomical target leads to optimal outcome. Subthalamic nucleus (STN) and globus pallidus internus (GPi) DBS has become valuable surgical stimulation sites, mainly improving the motor symptoms. The effects of DBS on cognitive function is less well understood and there is the suggestion that GPi DBS may be better tolerated with respect to cognitive adverse effects. It is still unclear, on a patient-specific level, which surgical target provides the best balance between treatment efficacy, safety, and minimization of adverse effects. We hypothesize that PD patients undergoing DBS demonstrate structural and connectivity related changes seen on preoperative MRI. The identification of imaging-based biomarkers could predict surgical response to DBS therapy and aid in personalized surgical target selection. To this end, 542 PD patients with preoperative structural and functional imaging and undergoing STN or GPi DBS have been recruited through our centre. We aim to leverage this uniquely large disease cohort, rich multi-modal imaging dataset, and predictive analytic techniques to identify imaging biomarkers for predicting response to DBS. This can be readily translated towards improving DBS therapy through patient-specific surgical target selection.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466682
Name
Santyr Brendan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Multimodal MRI biomarkers for optimizing deep brain stimulation therapy in Parkinson's disease.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Deep Brain Stimulation; Magnetic Resonance Imaging; Medical Imaging; Movement Disorders; Neurosurgery; Outcome Prediction; Parkinson'S Disease
Abstract
Deep brain stimulation (DBS) is a neurosurgical technique wherein implantable electrodes are placed in key brain structures to provide electrical stimulation and modulate pathological brain activity. It has become an effective and well-established therapy for Parkinsons disease (PD) and has shown benefit for an expanding number of motor, psychiatric, and cognitive disorders. Despite its recognized efficacy in PD, there is substantial variability in clinical response and there remains uncertainty as to which neuroanatomical target leads to optimal outcome. Subthalamic nucleus (STN) and globus pallidus internus (GPi) DBS has become valuable surgical stimulation sites, mainly improving the motor symptoms. The effects of DBS on cognitive function is less well understood and there is the suggestion that GPi DBS may be better tolerated with respect to cognitive adverse effects. It is still unclear, on a patient-specific level, which surgical target provides the best balance between treatment efficacy, safety, and minimization of adverse effects. We hypothesize that PD patients undergoing DBS demonstrate structural and connectivity related changes seen on preoperative MRI. The identification of imaging-based biomarkers could predict surgical response to DBS therapy and aid in personalized surgical target selection. To this end, 542 PD patients with preoperative structural and functional imaging and undergoing STN or GPi DBS have been recruited through our centre. We aim to leverage this uniquely large disease cohort, rich multi-modal imaging dataset, and predictive analytic techniques to identify imaging biomarkers for predicting response to DBS. This can be readily translated towards improving DBS therapy through patient-specific surgical target selection.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Santyr, Brendan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~